ArticleInternational journal of nanomedicine2022

A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues.

Jiaojiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.